Stress-up-regulated myocardial endothelin receptors are suppressed by chlorobenzyltetrahydroberberine CPU86017 and its RS chiral isomer

Journal of China Pharmaceutical University

Volumn 40, Issue 4, 2009, Pages 374-379

  Hu, Chen ^a   Yu, Feng ^a   Dai, De Zai ^a   Dai, Yin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Chiral isomer; Chlorobenzyltetrahydroberberine; CPU86017; ETA; ETB; Isoproterenol; Oxidative stress

Indexed keywords

CHLOROBENZYLTETRAHYDROBERBERINE; CPU 86017; ENDOTHELIN RECEPTOR; ISOPRENALINE; PROPRANOLOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CARDIOVASCULAR EFFECT; CHEMICAL STRUCTURE; ENZYME INHIBITION; HEART MUSCLE CELL; ISOMER; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

EID: 69949184943     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wehrens XH, Marks AR. Molecular deter minants of altered contractility in heart failure[J]. Ann Med,2004,36(Suppl 1):70-80.
2. Xu FP, Chen MS, Wang YZ, et al. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes[J]. Circulation,2004,110(10):1 269-1 275.
3. Xia HJ, Dai DZ, Dai Y. Up-regulated inflammatory factors endothelin , NFkappaB, TNFalpha and iNOS involved in exaggerated cardiac arrhythmias in 1-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats[J]. Life Sci,2006,79(19):1 812-1 819.
4. Na T, Huang ZJ, Dai DZ, et al. Abrupt changes in FKBP12. 6 and SERCA2a expression contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017[J]. Acta Pharmacol Sin,2007,28(6):773-782.
5. Dai DZ. CPU86017: a novel Class III antiarrhythmic agent with multiple actions at ion channels[J]. Cardiovasc Drug Rev,2006,24(2):101-115.
6. Zareba W, Cygankiewicz I. Long QT syndrome and short QT syndrome[J]. Prog Cardiovasc Dis,2008,51(3):264-278.
7. Ertl G, Bauersachs J. Endothelin receptor antagonists in heart failure: current status and future directions[J]. Drugs,2004,64(10):1 029-1 040.
8. Saka M, Obata K, Ichihara S, et al. Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure[J]. J Cardiovasc Pharmacol,2006,47(6):770-779.
9. Dai DZ, Dai Y. Induced ion currents and the endothelin pathway as targets for anti-arrhythmic agents[J]. Curr Opin Investig Drugs,2008,9(9):1 001 -1 008.
10. Mohácsi A.Magyar J, Tamás B, et al. Effects of endothelins on cardiac and vascular cells : new therapeutic target for the future[J]? Curr Vasc Pharmacol,2004,2(1):53-63.
11. Dura F, Barton M, Lüscher TF, et al. Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs[J]? Cardiovasc Res,2001,49(2):272-280.
12. Feng Y, Tang XY, Dai DZ, et al. Reversal of isoproterenol-induced downregulation of phospholamban and FKBP12. 6 by CPU0213-mediated antagonism of endothelin receptors[J]. Acta Pharmacol Sin,2007,28(11):1 746-1 754.
13. Wang HL, Dai DZ, Gao E, et al. Dispersion of ventricular mRNA of RyR2 and SERCA2 associated with arrhythmogenesis in rats[J]. Acta Pharmacol Sin,2004,25(6):738-743.
14. Schneider MP, Boesen EI, Pollock DM. Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease[J]. Anna Rev Pharmacol Toxicol,2007,47:731-759.
15. Dong F, Zhang X, Wold LE, et al. Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1[J]. Br J Pharmacol,2005,145(3):323-333.
16. Loomis ED, Sullivan JC, Osmond DA, et al. Endothelin mediates superoxide production and vasoconstriction through activation of NADPH oxidase and uncoupled nitric-oxide synthase in the rat aorta[J]. J Pharmacol Exp Ther,2005,315(3):1 058-1 064.
17. Xu M, Dai DZ, Dai Y, Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by a dual endothelin receptor antagonist CPU0213 in rats[J]. Am J Nephrol,2009,29(3):252-256.
18. Lu H. Stereoselectivity in drug metabolism[J]. Expert Opin Drug Metab Toxicol,2007,3(2):149-158.
19. Ciamala CD, Wang ZZ, Dai DZ. Difference in cardiovascalar activities of CPU-86017 between Rat and Rabbit by in and icv rentes , and potential relation to endotheliam[J]. J Chin Pharm Univ,2002,33(5):428-433.
20. Li N, Dai DZ, Dai Y. CPU86017 and its isomers improve hypoxic pulmonary hypertension by attenuating increased ETA receptor expression and extracellular matrix accumulation[J]. Naunyn Schmiedebergs Arch Pharmacol,2008,378(5):541-552.